Las Vegas, NV -- (SBWIRE) -- 01/24/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Briggs & Stratton Corporation (NYSE:BGG), Vonage Holdings Corp.(NYSE:VG), Chelsea Therapeutics International Ltd.(NASDAQ:CHTP), Dynavax Technologies Corporation(NASDAQ:DVAX)
Briggs & Stratton Corporation (NYSE:BGG) was a volume gainer of 3.30 million shares and the average volume of the stock remained 350,893.00 shares. The stock opened the session at $20.70 and finished at the end of the day at $21.20 and the stock plunged -6.73% .The market capitalizations of the stock remained 1.01 billion. Briggs & Stratton Corporation designs, manufactures, markets, and services air cooled gasoline engines for outdoor power equipment. It operates in two segments, Engines and Products. Briggs & Stratton Corporation was founded in 1908 and is based in Wauwatosa, Wisconsin.
Has BGG Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Vonage Holdings Corp.(NYSE:VG) exchanged 3.26 million shares and the average volume remained 1.72 million shares. The stock closed the session at $4.42 with the drop of -2.21%. Vonage Holdings Corp. provides communications services that connect individuals through cloud-connected devices worldwide. The company offers voice and messaging services through session initiation protocol based voice over Internet protocol network. Vonage Holdings Corp. was incorporated in 2000 and is headquartered in Holmdel, New Jersey.
Why Should Investors Buy VG After the Recent Fall? Just Go Here and Find Out
Chelsea Therapeutics International Ltd.(NASDAQ:CHTP) enhanced 3.55% and its closing price was $4.81. The volume of the stock was 3.25 million shares and the average volume remained 5.62 million shares. The market capitalization of the stock remained 377.27 million. Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina.
Why Should Investors Buy CHTP After The Recent Gain? Just Go Here and Find Out
Dynavax Technologies Corporation(NASDAQ:DVAX) exchanged 3.24 million shares in the previous trading session, and its average trading remained 5.20 million shares. DVAX it closed the trading at $1.94. The market capitalization of the stock remained 509.49 million. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California.
How Should Investors Trade DVAX Now? Don’t Miss out a Special Trend Analysis
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)